Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
June 21 2021 - 5:31PM
Edgar (US Regulatory)
Filed by Apex Technology Acquisition Corporation
Pursuant to Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
of the Securities Exchange Act of 1934
Subject Company: Apex Technology Acquisition Corporation
Commission File No. 001-39048
EXPLANATORY NOTE
On
June 21, 2021, MacKenzie Partners, Inc., acting as proxy solicitor on behalf of Apex Technology Acquisition Corporation (the Company) in connection with the Companys upcoming special meeting of stockholders to be held on
June 30, 2021 (the Special Meeting), sent the below letter to certain holders of record of the Companys common stock in order to encourage such stockholders to vote their shares in the Special Meeting.
|
|
|
|
|
1407 Broadway 27th Floor, New York, NY, 10018
Tel: 212-929-5500 Fax: 212-929-0308
Email: proxy@mackenziepartners.com
New York London Los
Angeles Palo Alto
|
Please Contact MacKenzie Partners Today
To Vote Your Apex Technology Acquisition Corp. Shares!
June 21, 2021
Dear Apex Stockholder:
The Special Meeting of Stockholders of Apex Technology Acquisition Corporation is scheduled to be held on June 30, 2021.
It is very important that all stockholders have their voices heard. We urge you to please vote your Apex shares today. You may do so by contacting
MacKenzie Partners toll-free at 1-888-410-7851. MacKenzie has been engaged by Apex to assist in gathering the votes at
the Special Meeting.
No matter how many shares you hold, your vote is very important. Please contact MacKenzie Partners today so that we may assist in
processing your vote this will only take a few minutes of your time.
MacKenzies team of representatives can be reached toll-free at 1-888-410-7851.
You may also contact us
with your voting instructions via email at: proxy@mackenziepartners.com. Here is a sample email:
Please let this email serve as my authorization to
vote my_____ shares of Apex Technology Acquisition
Corporation stock as follows:
|
1.
|
FOR the Business Combination.
|
|
2a.
|
FOR changing Apexs name to AvePoint, Inc.
|
|
2b.
|
FOR increasing the number of authorized shares of common and blank check preferred stock
|
|
2c.
|
FOR requiring that stockholders only act at annual and special meetings of the corporation and not by written
consent.
|
|
2d.
|
FOR eliminating the current limitations in place on the corporate opportunity doctrine.
|
|
2e.
|
FOR increasing the required vote thresholds for stockholders approving amendments to the certificate of
incorporation and bylaws to 66 2/3%.
|
|
2f.
|
FOR approving all other changes, including eliminating certain provisions related to special purpose
acquisition corporations that will no longer be relevant following consummation of the Business Combination.
|
|
3.
|
FOR approving the AvePoint, Inc. 2021 Equity Incentive Plan.
|
|
4.
|
FOR approving the AvePoint, Inc. 2021 Employee Stock Purchase Plan.
|
|
5a.
|
FOR issuing Apex common stock to AvePoints equityholders in connection with the merger pursuant to the
Business Combination Agreement.
|
|
5b.
|
FOR issuing Apex common stock to investors in the PIPE.
|
|
6.
|
FOR approving the adjournment of the Special Meeting if necessary.
|
The shares are registered in the name of ______________________.
Sincerely,
MacKenzie Partners, Inc.
Toll-Free at 1-888-410-7851
Important Information for Investors and Shareholders
This communication relates to a proposed transaction between Apex Technology Acquisition Corporation (APXT) and AvePoint, Inc.
(AvePoint). In connection with the proposed transaction, APXT has filed a registration statement on Form S-4 with the SEC, which also includes a document that serves as a prospectus and
proxy statement of APXT, referred to as a proxy statement/prospectus. A proxy statement/prospectus has been sent all APXT shareholders. APXT will file other documents regarding the proposed transaction with the SEC. Before making any voting
decision, investors and security holders of APXT are urged to read the registration statement, the proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC in connection with the proposed transaction as
they become available because they will contain important information about the proposed transaction. Investors and security holders are able to obtain free copies of the registration statement, the proxy statement/prospectus and all other relevant
documents filed or that will be filed with the SEC by APXT through the website maintained by the SEC at www.sec.gov.
Participants in the
Solicitation
APXT and its directors and officers may be deemed participants in the solicitation of proxies of APXTs shareholders in connection
with the proposed transaction. APXTs shareholders and other interested persons may obtain, without charge, more detailed information regarding the directors and officers of APXT in the registration statement containing the proxy
statement/prospectus which has been filed with the SEC.
Apex Technology Acquisit... (NASDAQ:APXTU)
Historical Stock Chart
From Jun 2024 to Jul 2024
Apex Technology Acquisit... (NASDAQ:APXTU)
Historical Stock Chart
From Jul 2023 to Jul 2024